Stock NB3 NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Neurocrine Biosciences, Inc. Deutsche Boerse AG

Equities

NB3

US64125C1099

Market Closed - Deutsche Boerse AG
Other stock markets
 07:02:51 07/06/2024 BST 		5-day change 1st Jan Change
121.6 EUR -0.37% Intraday chart for Neurocrine Biosciences, Inc. -1.93% +2.36%
06-05 Transcript : Neurocrine Biosciences, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 02:30 PM
06-03 Neurocrine Biosciences, Inc. Announces Publication of Primary CAHtalyst Adult Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine CI
86bb8e95510cab5.LnvbQK-Tdmg2gjMJUQBsGQ9vlFQVmMmb7QxZ-IumeO4.SBCKc8SqKSdxsX9AHFU6bkouzjx2yKLh3H4dwb7gK9sdHoR59_YOHkfvcg~4fe78420c0ae0ff173bb56b4c8acf499
  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. NB3 Stock
  5. Charts Neurocrine Biosciences, Inc.
  6. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW